Clinical outcomes are complex and often involve multiple systemic burdens. Early identification and standardized clinical care are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical outcomes, imaging inspections, laboratory tests and pathological evaluation.
The platform can assist in matching teams of nationally and internationally authoritative experts to provide accurate diagnosis and treatment programs. Treatment and management of systemic fibrosis requires individualized development, typically including pharmacotherapy, rehabilitation, regular follow-up, and multidimensional management. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many autoimmune and rheumatic immune diseases that were previously difficult to treat have been significantly improved.
Therapeutic efficacy and adverse reactions need to be closely monitored and timely adjusted according to changes in the course of treatment. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of systemic fibrosis. The platform serves a team of internationally authoritative experts in the field of self-immunity and rheumatic immunity in China.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.